Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 March 2022 | Story Lacea Loader

On 14 March 2022, the Bloemfontein and Qwaqwa Campuses of the University of the Free State (UFS) will return to face-to-face classes as per the teaching plans for 2022. The faculties that are continuing with face-to-face classes in the first term (i.e., the Faculties of Natural and Agricultural Sciences and Health Sciences), will remain face-to-face during the week of 7 to 11 March 2022.

The decision to resume face-to-face classes follows previous communiques in February 2022 about the temporary closure of the Qwaqwa Campus due to violent protest action, and the continuation of the academic programme on the Bloemfontein Campus in a differentiated and flexible online delivery mode due to challenges experienced with disruption of classes. 
 
The return to face-to-face classes on 14 March 2022 also follows the reopening of and resumption of online classes on the Qwaqwa Campus on 28 February 2022, and the resumption of some face-to-face activity on the Qwaqwa Campus as from 7 March 2022.

As a residential institution, it is important for students to return to campus, for the academic programme to continue as planned, and for activities to return to normal.
 
Students will be informed by their respective faculties as to how the academic programme will be adapted for face-to-face classes, including instances where classes will remain online.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept